Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The coronavirus 3C-like protease, also known as 3CLpro or main protease (Mpro), is a cysteine protease essential for the life cycle of coronaviruses. It cleaves viral polyproteins pp1a and pp1ab at conserved sites to release functional non-structural proteins (nsps) required for viral replication and transcription. Inhibitors targeting its active site block polyprotein processing and halt virus replication. Its high conservation across coronaviruses makes it a promising target for broad-spectrum antiviral drug development.
Inhibition of viral polyprotein processing, thereby blocking viral replication.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coronavirus 3C-like protease (None).